Brief: Lipigon Pharmaceuticals Q1 Operating Loss Widens To SEK 4.9 Mln
19/05/2021 09:01
May 19 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST :
* Q1 OPERATING LOSS SEK 4.9 MILLION VERSUS LOSS SEK 0.9
MILLION
YEAR AGO
* Q1 NET SALES SEK 794 000 VERSUS SEK 707 000 YEAR AGO
Source text for Eikon: ID:nBQN9VjHRs
Further company coverage: LPGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds